Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression
- 29 December 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 247, 115071
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implicationsNeuroscience, 2013
- Ligand-Optimized Homology Models of D1 and D2 Dopamine Receptors: Application for Virtual ScreeningJournal of Chemical Information and Modeling, 2013
- A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illnessProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- The GABAergic deficit hypothesis of major depressive disorderMolecular Psychiatry, 2010
- Astrocytes are GABAergic cells that modulate microglial activityGlia, 2010
- Interleukin-1 Receptor Activation by Systemic Lipopolysaccharide Induces Behavioral Despair Linked to MAPK Regulation of CNS Serotonin TransportersNeuropsychopharmacology, 2010
- Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive DisorderBiological Psychiatry, 2009
- GABAergic activities enhance macrophage inflammatory protein‐1α release from microglia (brain macrophages) in postnatal mouse brainThe Journal of Physiology, 2009
- Cytokine Production and Treatment Response in Major Depressive DisorderNeuropsychopharmacology, 2000
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973